Bolivia AGEMED, ATT, IBMETRO, SENASAG and Customs: Parallel Approval Gates

1. Key takeaways

Medical device compliance in Bolivia is a parallel multi-gate structure, and AGEMED is responsible only for the sanitary registration. Equipment with wireless modules must pass type approval at ATT, the Bolivian regulatory authority for telecommunications and transport, with the basic basis being Resolución ATT-DJ-RAR-TL LP 539/2024; ATT published the list of equipment subject to homologation on January 28, 2026 and updated it on February 25, 2026. Products involving metrological functions must address the corresponding filings with IBMETRO; products of animal or plant origin, or food products, involve SENASAG; and all imports ultimately pass customs and the clearance authorization certificate (CADA) administered with AGEMED. GRZAN’s assessment is that the gate most frequently left out of the plan is ATT type approval: it sits outside the AGEMED procedure, yet it directly blocks customs clearance, so a shipment that has cleared sanitary registration can still be held at the border for want of a homologation certificate.

The parallel structure also allocates risk differently from single-window systems. In a single-window system, a missing approval is discovered during the review, while the applicant is still in a dialogue with the agency. In a parallel system, each gate is silent until its own requirement is tested, and the first place where all gates are tested together is the customs border, under time pressure and with goods already paid for. This is why the screening recommended below belongs at project initiation, not at shipping: identifying every applicable gate early converts the customs stage from a discovery process into a confirmation process, which is what the CADA paperwork assumes it will be.

2. Legal basis

3. Expert insights

Insight one: the ATT list update pulls the IoT category into the approval scope. The version of the list dated February 25, 2026 adds LoRaWAN, RFID, short-range devices (SRD), and FM/AM receivers, and it uses February 25, 2026 as the cut-off between the old list and the new one: submissions made before that date are reviewed under the old list, and submissions after it under the new list. ATT also made clear that it no longer issues declarations of non-requirement for homologation: the previous practice of clearing equipment with a waiver letter no longer works, and there is no administrative exit for a device that appears on the list.

Insight two: medical telemetry systems are already within the regulated descriptions. This brings remote monitoring and wearable follow-up devices directly under the prior approval requirement. Manufacturers and importers must place it on the critical path of the project plan and cannot treat it as a dispensable communication accessory, because the radio function, not the medical function, is what triggers the obligation.

Insight three: the parallel gates fall due at different points, and misalignment means delay. The responsible entities and the prerequisites differ among the AGEMED sanitary registration, ATT approval, and the customs CADA. GRZAN recommends scheduling on the principle of parallel start, converging at customs clearance, rather than waiting for the sanitary registration to be granted before starting ATT, which would turn what could be run in parallel into a serial queue at the border.

Insight four: SENASAG and IBMETRO are narrower gates but not negligible ones. Most device projects will never touch SENASAG, because its remit covers animal and plant origin and food products. But a device line that includes, for example, products of animal origin such as certain collagen-based or gelatin-based materials, or nutrition-related products sold alongside the device line, can trigger it unexpectedly. IBMETRO applies where a measuring function is part of the regulated use of the instrument. Both gates share the same planning rule as ATT: they are cheap to screen at initiation and expensive to discover at clearance, and neither can be satisfied by the sanitary registration itself.

4. Practical recommendations

The recommendations below are sequenced so that the widest gate is screened first. The wireless attribute screen covers the largest share of modern device portfolios and the gate that blocks clearance most often; the ATT cycle reserve follows, because the timeline is long enough to sit on the critical path even when started early; and the list-confirmation step closes the loop, protecting the technical solution from a mid-project list revision. Together they take days of planning and save weeks of border delay.

A closing reminder on responsibilities: the gates belong to different institutions, but the consequence of missing any of them lands on the same shipment and the same importer of record. Making one person on the project team the owner of the full gate map, with each gate marked as not applicable, in progress, or cleared, is the simplest control against the partial-compliance scenario in which every individual workstream is on schedule and the shipment as a whole is not.

1. Run a wireless attribute screen at the project initiation stage: any product containing Bluetooth, Wi-Fi, cellular, LoRa, or RFID modules is entered into the ATT approval task list without exception.
2. Reserve 7 to 12 weeks for the ATT cycle (practical estimate), run in parallel with the sanitary registration.
3. Confirm the applicability of the current ATT list with ATT before fixing the technical solution, to avoid a redesign caused by a list revision mid-project.

5. Verification checklist

• □ Does the product contain any radio transmission or reception module
• □ Has applicability been confirmed against the ATT list version of February 25, 2026
• □ Has the ATT approval been started in parallel with the sanitary registration
• □ Do IBMETRO metrological filing obligations apply
• □ Has the list of accompanying documents for customs clearance CADA been aligned with the customs broker

Regulatory information verified as of October 29, 2026.

GRZAN supports manufacturers, importers, and authorized representatives with medical device registration in Bolivia, covering dossier preparation, local entity coordination, and regulatory strategy. Contact info@grzanglobal.com for project inquiries.